Integral control of risk factors in patients of high and very high cardiovascular risk in Spain.: CIFARC project

被引:32
作者
Fernández, CS
Melero, IC
Rodríguez, MM
Cánovas, JG
Babkowski, MC
Villanueva, BR
Pedraja, JA
机构
[1] Fdn Hosp Llatzer, Med Interna Serv, Palma de Mallorca, Mallorca, Spain
[2] Hosp Provincial San Telmo, Med Interna Serv, Palencia, Spain
[3] Hosp Leon, Med Interna Serv, Leon, Spain
[4] Clin Virgen Vega, Med Interna Serv, Murcia, Spain
[5] Hosp Comarcal Mora Ebre, Med Interna Serv, Tarragona, Spain
[6] Hosp Gen Castellon, Med Interna Serv, Castellon De La Plana, Spain
[7] Hosp Valle Pedroches, Med Interna Serv, Cordoba, Spain
来源
MEDICINA CLINICA | 2005年 / 124卷 / 02期
关键词
integral control cardiovascular risk factors; high cardiovascular risk;
D O I
10.1157/13070450
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVE: The objective of this study was to determine the percentage of patients kith high and very high cardiovascular risk, with their risk factors globally well controlled (hypertension, dyslipemia, diabetes mellitus, tobacco and obesity). PATIENTS AND METHOD: Transversal study of ambulatory patients of internal medicine with an estimated cardiovascular risk high or very high (Framingham stratification scale over 20% in ten years). We evaluated the degree of control of their cardiovascular risk factors attending to the recommendations provided by recent international guidelines (WHO/ISH, JNC-VI, NCEP-ATP-III, ADA). RESULTS: We studied 2,264 patients (53.7% males; mean age: 66.1 +/- 11.5 years; 74.6% hypertensive, 61.1% dyslipidemic, 59.8% type 2 diabetes, 31.1% smokers, 38.0% obese and 36.7% in secondary prevention). Control of hypertension was achieved in 34.5%, dyslipidemia in 50.3% and diabetes in 35.5%. Global control of every risk factor was achieved in 6.9% (in 10.2% if we exclude obesity since it is not a risk factor used for cardiovascular stratification). Factors independently associated with a bad integral control were: diabetes (OR = 0.33; 95%Cl: 0.23-0.47), dyslipidemia (OR = 0.34; 95%CI: 0.24-0.48), proteinuria (OR = 0.36; 95%CI: 0.18-0.71). Factors independently associated with a better cardiovascular control were: male sex (OR = 1.67; 95%CI: 1.18-2.38), ventricular hypertrophy (OR = 1.62; 95%CI: 1.15-2.30) and the number of exploratory tests (OR 1.01; 95%CI: 1.01-1.08). CONCLUSIONS: Only 6.9% of patients with a high or very high cardiovascular risk have all their principal risk factors under control. The presence of diabetes, dyslipidemia or proteinuria predisposed to a worse control and the number of complementary tests performed to the patients was related to a better control.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 22 条
[1]  
BARRIOS V, 2002, HIPERTENSION, V19, P1
[2]  
BARRIOS V, 2003, 29 C SOC ESP CARD OC
[3]  
Chalmers J, 1999, J HYPERTENS, V17, P151
[4]  
Clark CM, 1997, DIABETES CARE, V20, P1
[5]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[6]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[7]   Evaluation on the compliance of the metabolic control aims in outpatients with type 2 diabetes mellitus in Spain.: The TranSTAR study [J].
de la Calle, H ;
Costa, A ;
Díez-Espino, J ;
Franch, J ;
Goday, A .
MEDICINA CLINICA, 2003, 120 (12) :446-450
[8]   New data on secondary prevention of myocardial infarction in Spain.: Results of the PREVESE II Study [J].
de Velasco, JA ;
Cosín, J ;
López-Sendón, JL ;
de Teresa, E ;
de Oya, M ;
Sellers, MD .
REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (08) :801-809
[9]   Secondary prevention of myocardial infarction in Spain. PREVESE study [J].
deVelasco, JA ;
Cosin, J ;
Sendon, JLL ;
deTeresa, E ;
deOya, M ;
Carrasco, JL ;
Navarro, A .
REVISTA ESPANOLA DE CARDIOLOGIA, 1997, 50 (06) :406-415
[10]   Secondary prevention of stroke in Italy - A cross-sectional survey in family practice [J].
Filippi, A ;
Bignamini, AA ;
Sessa, E ;
Samani, F ;
Mazzaglia, G .
STROKE, 2003, 34 (04) :1010-1014